Skip to main content

Table 6 Previous studies validating BICAMS

From: Reliability and validity of Arabic version of the brief international cognitive assessment for multiple sclerosis: Egyptian dialect

Study country

Czech Republic19

Italy20,21

Brazil22

Brazil23*

Lithuania24

Ireland25

Hungary26

Canada27

America28

Argentina29

Greece30#

Belgium31

Turkey32

Portgal33

German34Ψ

Japan35

No.

PwMS

369

192

58

34

50

67

65

57

41

50

44

97

173

105

172

156

HC

134

273

58

-

20

66

65

51

32

100

79

97

153

60

100

126

Age of PwMS (year) Mean±SD

34±10

41.4±10.8

41.2±12.2

43.4±10.8

38.8±10.2

43.9±12.1

41.9±8.9

45.4±9.9

46.7±8.6

43.4± 10.2

40.2±9.9

45.4±9.2

37.5 ± 10.7

38.3±11

43.3±11.6

41.4±9.3

Years of education Mean±SD

14±3

12.3±3.5

12.7±5.2

15% ≤ 8

38% 8-11

29% 11–18

18% >18

15.9±2.8

13.6±2.7

48% ≤12

52% ≥ 13

15.44±2.7

15.2±2.2

14.9 ± 2.8

14.1±4.8

14.3±1.9

13.9 ± 7.3

13.6±3.7

-

14.1±1.9

Disease duration (year) Mean±SD/Median

8±7

12.7 ± 8.9

8.3±6.6

9.47±7.9

11.7±9.2

10.2± 8.4

11.1±7.6

10.1± 7.7

12.7±8.2

13.1±9.1

9.1±4.1

13± 7.2

9.2 ± 6.1

6.5 ±6

-

10.3±7.2

EDSS mean±SD

3±1.5

2.7±1.7

4.2±2

3.4±1.3

3.3±1.3

1.8±0.9 (RRMS)

5.7±1.4 (SPMS)

7 (PPMS)

2.5±1.8

2.7± 1.9

-

3.3 ±2.6

3.5

3.5±2.5

2.4 ± 1.7

1.5

-

2.4±2.0

SDMT

HC Mean±SD

65± 9

56.3±11.3

47.5±13

56.3±10.3

57.7±11.5

55.9±10.9

66.8±12.4

59.1± 8.5

60.7±9.2

56.7± 10.9

61.4±13.1

61±10.2

53.5± 9.5

58.7 ±10

56.1±11.6

61.0±9.5

PwMS

Mean±SD

50±13

46.4±12.8

35.9±16.1

48.5±14.9

42.7±13.9

46 ±12.9

55.6±15.5

49.7± 10.8

51.7±11.7

45.1±16.1

45.0±17.2

52.1±13.1

43.2 ± 12.5

51.8±11.2

47.4± 11.7

(BL)

47.9±14

% with impairment

42

19 in all tests

-

67

-

-

-

28.1

-

-

43

-

41

14.3

19.2

-

CVLT

HC Mean±SD

60±8

56.3± 9

 

58.4±8.3

65.7±5.9

52.8± 8.8

59± 8.3

57.7± 7.9

60.8±9

60.9± 10.5

60.5±10.7

61.3±9.7

53.9 ± 7.7

60.5±10

55.2± 10.3

55.7±10.5

PwMS

mean±SD

52±11

49.9±12.1

42.1 ± 12.4

48.2±8.6

55.9±10

45.3±10.2

55.4 ± 10.7

51.6± 10.1

53.6±10.9

50.9±12.4

55.5±12.3

60.1±12.9

45.7±11.3

55.1± 11.9

55.4±11.4

(VLMT)

(BL)

48.6±12.6

% with impairment

22

19 in all tests

-

73

-

40

-

26.3

-

-

20

-

38.2

9.5

8.1(on VLMT)

-

BVRT

HC mean±SD

29±4

27.9±6.1

23.8 ± 7.7

26.2±8.3

29.6±4.1

20.7± 6.6

26.7 ±5.6

29.8±3.6

25.7±6.3

23.4± 5.8

22.1±6.5

25.4±7.3

22.5±9.2

24.7 ± 5.5

27.4±6

28.3±5.4

PwMS

mean±SD

23±7

23.7±8

19.9 ± 8.6

23.5±6.7

23.1±7

17.9 ±7.1

22.54± 8.5

24.6±6.5

21.3±7

20.7±7.7

18.5±8.3

28.2±5.1

16.9 ± 8.5

21.7± 7.3

24.4±7.6

(BL)

23.5±8.4

% with impairment

41

19 in all tests

-

58

-

10

-

43.9

-

-

22

 

33.5

11.4

26.5

-

  1. *Used 1SD of the mean for cutoff and means of HCs were norms from previous studies
  2. #Instead of the CVLT-II, the Greek Adaptation Greek Verbal Learning Test (GVLT) was used
  3. ΨInstead of CVLT-II, the Rey Auditory Verbal Learning Test (RAVLT) German version: Verbaler Lern- und Merkfähigkeits-Test, (VLMT) was chosen as verbal short-term memory and learning test.
  4. No. number, HC healthy controls, PwMS Patients with Multiple Sclerosis, EDSS Expanded Disability Status Scale, SDMT Symbol Digit Modality Test, CVLT California Verbal Learning Test, BVRT Brief Visuospatial Retention Test, BL baseline
  5. RRMS relapsing remitting, MS SPMS secondary progressive, MS PPMS primary progressive MS